|
Post by Gort on Jun 17, 2021 22:47:30 GMT 10
A friend of the family had his first AZ vaccine a couple of weeks ago. He is in his 80s
It really knocked him for 6.
No energy, very unwell and buggered up his diabetes. He wound up in the emergency department.
I've decided to forgo the AZ vaccine.
|
|
|
Post by caskur on Jun 17, 2021 23:22:50 GMT 10
Read this... truth11.com/2021/05/07/reported-vaccine-injuries-continue-to-climb-pfizer-seeks-full-approval-for-covid-vaccine/Reported Vaccine Injuries Continue to Climb, Pfizer Seeks Full Approval for COVID Vaccine Reported Vaccine Injuries Continue to Climb, Pfizer Seeks Full Approval for COVID Vaccine Children’s Health Defense » Feed The number of reports of injuries and deaths following COVID vaccines continues to rise, according to data released today by the Centers for Disease Control and Prevention (CDC). The data comes directly from reports submitted to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Today’s data show that between Dec. 14, 2020 and April 30, a total of 157,277 total adverse events were reported to VAERS, including 3,837 deaths — an increase of 293 over the previous week — and 16,014 serious injuries, up 2,467 since last week.
|
|
|
Post by caskur on Jun 17, 2021 23:23:00 GMT 10
In the U.S., 240.2 million COVID vaccine doses had been administered as of April 30. This includes 105 million doses of Moderna’s vaccine, 127 million doses of Pfizer and 8 million doses of the Johnson &Johnson (J&J) COVID vaccine. Of the 3,837 deaths reported as of April 30, 24% occurred within 48 hours of vaccination, 16% occurred within 24 hours and 39% occurred in people who became ill within 48 hours of being vaccinated. This week’s VAERS data show: 21% of deaths were related to cardiac disorders. 54% of those who died were male, 44% were female and the remaining death reports did not include gender of the deceased. The average age of death was 75.1 and the youngest deaths reported include two 15-year-olds (VAERS I.D. 1187918 and 1242573 ) and a 16-year-old (VAERS I.D. 1225942). There were other reported deaths in children under 16 that could not be confirmed or contained obvious errors. As of April 30, 805 pregnant women reported adverse events related to COVID vaccines, including 235 reports of miscarriage or premature birth. Of the 1,597 cases of Bell’s Palsy reported, 51% were reported after Pfizer-BioNTech vaccinations, 40% following vaccination with the Moderna vaccine and 131 cases, or 10%, of Bell’s Palsy cases were reported in conjunction with J&J. There were 162 reports of Guillain-Barré Syndrome with 41% of cases attributed to Pfizer, 45% to Moderna and 19% to J&J. There were 44,348 reports of anaphylaxis with 38% of cases attributed to Pfizer’s vaccine, 47% to Moderna and 14% to J&J. FDA set to authorize Pfizer vaccine for young teens On May 4, The Defender reported the U.S. Food and Drug Administration (FDA) is preparing to authorize use of the Pfizer-BioNTech COVID vaccine in adolescents 12 to 15 years old by early next week. The company said it also plans to ask the FDA to expand Emergency Use Authorization for its vaccine for children ages 2 to 11 in September. According to CDC data, the death rate among adolescents ages 0 to 17 who get COVID and are subsequently hospitalized is 0.7%, with many experiencing either mild or no symptoms at all. The COVID death rate in all adolescent age categories is less than 0.1%, leading some experts to question whether vaccines should be targeted to an age group that so far appears to be mostly spared from severe COVID. As CNN reported Friday, Pfizer filed for full FDA approval for its COVID vaccine for people ages 16 and up. The FDA requires vaccine manufacturers submit data on manufacturing processes, facilities and additional information that demonstrates the vaccine can be produced reliably and consistently. Once all the required information is submitted, a goal date will be set for a decision by the FDA. Pfizer requested priority review, which asks the FDA to take action within six months, compared to 10 months designated under standard review. Third U.S. male diagnosed with vaccine-induced blood clots, woman dies from brain hemorrhage after J&J vaccine On May 6, The Defender reported doctors at University of Utah Health treated the third male to develop vaccine-induced thrombotic thrombocytopenia in the U.S. The man, under age 50, received J&J’s vaccine in early April. Ten days later he experienced pain in his toes, which then progressed to his thighs. He later began experiencing chest pain. A CT scan revealed a bilateral pulmonary embolism. Physicians discovered low platelets and blood clots in his legs and lungs, leading them to suspect VITT was the cause. On May 4, The Defender reported a 35-year-old Michigan woman died from complications 11 days after receiving J&J’s vaccine. The woman’s family said her headache started on April 16 — eight days after being vaccinated. She died three days later. Her death certificate notes a natural death, specifically from an acute subarachnoid hemorrhage, or bleeding between the brain and tissue around the brain. The attending physician filed a report to VAERS. In an email to the family, the CDC confirmed her death had been reported to VAERS, but said the system is not designed to determine whether a reported adverse event was caused by the vaccine. Children’s Health Defense queried the VAERS data for adverse events associated with the formation of clotting disorders and other related conditions and found 2,808 reports for all three vaccines from Dec. 14, 2020, through April 30. Of the 2,808 cases reported, there were 1043 reports attributed to Pfizer, 893 reports to Moderna and 860 reports to J&J — 847 cases more than U.S. health officials acknowledged during the April 23 meeting where it was recommended the pause be lifted on J&J’s vaccine. Denmark ditches J&J vaccine On May 3, The Defender reported Denmark became the first country to exclude J&J’s COVID vaccine from its vaccination program over a potential link to blood clotting disorders. The Danish Health Authority said in a statement it had concluded “the benefits of using the COVID-19 vaccine from J&J do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine.” “Taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from COVID-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate,” the health authority said. Denmark stopped using AstraZeneca’s vaccine last month after European regulators found a possible link between the vaccine and “very rare” blood clots. CDC ignores The Defender, no response after two months According to the CDC website, “the CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.” The Defender reached out to the CDC on March 8 with a written list of questions about reported deaths and injuries related to COVID vaccines, the status of ongoing investigations reported in the media, if autopsies are being done, the standard for determining whether an injury is causally connected to a vaccine, and education initiatives to encourage and facilitate proper and accurate reporting. We have made numerous attempts to contact the CDC via phone and email. As of May 7, 60 days after our initial inquiry, we still have yet to receive answers to our questions. Children’s Health Defense asks anyone who has experienced an adverse reaction, to any vaccine, to file a report following these three steps. The post Reported Vaccine Injuries Continue to Climb, Pfizer Seeks Full Approval for COVID Vaccine appeared first on Children’s Health Defense. Original Article: childrenshealthdefense.org/defender/vaers-vaccine-injuries-climb-pfizer-seeks-full-approval/
|
|
|
Post by matte on Jun 18, 2021 8:07:18 GMT 10
This policy change is literally the final nail in the coffin for the AstraZeneca vaccine.
This is why we need Novavax.
|
|
|
Post by Occam's Spork on Jun 18, 2021 8:19:02 GMT 10
Beware for the third wave of propaganda, and the new strain of bullshit!
|
|
|
Post by Gort on Jun 19, 2021 12:17:37 GMT 10
|
|
|
Post by matte on Jun 19, 2021 21:41:00 GMT 10
A very informative article. We need to battle vaccine conspiracy theorists by having different types of vaccines available. The more people who get vaccinated, the better. We need more jabs in arms. Is Old Vaccine Technology the Key to Hesitancy? — Experts weigh whether Novavax's protein subunit strategy can convince some COVID vaccine holdouts
by Kristina Fiore 17 JUNE 2021 MEDPAGE TODAY Novavax's COVID-19 vaccine candidate could be the first authorized or approved in the U.S. to rely on a "tried and true" method for immunizing people against coronavirus. This purified protein, or protein subunit, vaccine strategy is used in many other vaccines on the market today -- so does it have a role to play in easing hesitancy to COVID vaccines? Experts in public health, infectious diseases, and vaccinology interviewed by MedPage Today said that while there are some notable caveats, it's certainly possible that having the option could help, and that they'd welcome anything that would get more people rolling up their sleeves. "At the end of the day, if someone is more comfortable with another vaccine, the goal should be to get people vaccinated," said Leana Wen, MD, an emergency physician and health policy expert at George Washington University and former health commissioner of Baltimore. "Having more options is always better. At this point when we have a surplus of vaccines, we should be offering individuals the choice as much as possible." William Schaffner, MD, an infectious disease expert at Vanderbilt University Medical Center in Nashville, said there could be an advantage in the emotional appeal of a vaccine strategy with an apparent track record. "Psychologists tell us that facts are essential, but what changes behavior is how people feel about something," Schaffner told MedPage Today. "They have to feel comfortable and reassured. ... Anything that will persuade some people to make them feel more comfortable in accepting a vaccine is something I endorse." But the available data on mRNA and adenoviral vector vaccines accumulated over the last 6 months shouldn't be overlooked, they noted. Purified Protein TechnologyFor Novavax's protein subunit vaccine candidate (known as NVX-CoV2373), spike protein is made by infecting cultures of insect (Spodoptera frugiperda) cells with a baculovirus that's been altered to contain genes for making the spike. The cells then churn out spike proteins, which are purified and mixed with an adjuvant to make the vaccine. The Novavax candidate contains the "Matrix-M" adjuvant, which is composed of the plant-derived glycoside saponin, cholesterol, and phospholipids. Paul Offit, MD, director of the Vaccine Education Center at Children's Hospital of Philadelphia, said this is the exact same technology used in the Flublok influenza vaccine, and is similar to other purified protein vaccines that have been around for a long time, like the hepatitis B vaccine. Other COVID-19 vaccines using more traditional technology are in development or in use in other countries, though it's not clear they'll become available in the U.S. Sanofi and GlaxoSmithKline announced in late May that they're starting a phase III trial for an adjuvanted recombinant protein vaccine similar to the one made by Novavax. Inactivated virus vaccines, another older strategy, include Covaxin in India and Sinopharm and CoronaVac in China. While there's certainly a track record of safety for these vaccine strategies, Offit says he's not sure this level of complexity would factor into decision-making at this point in time. "We've seen vaccine acceptance polling rise from 30% to 40% to 70% since December. Those are the people who are reassured by reason and logic and data," Offit told MedPage Today. "Then there's the access issue, that's being addressed. The third is inertia, where some people don't have a problem with it but haven't gotten around to it yet. Then there's a fourth group of science denialists who don't believe in what they're being told, or think that the disease is gone. These people won't believe in the government or the medical establishment or pharma." There's also the fact that if a vaccine does have a side effect, it will likely show up in the first 6 to 8 weeks of use, Offit said. "Of all the vaccines we use, in infancy, childhood, adolescence, and adulthood, none of them have any long-term effects," Schaffner said. "No vaccine has shown side effects 2 to 5 years later. That doesn't exist because there's no biological reason for it." Schaffner said the argument could also be made that "we know vastly more about mRNA vaccines than we do about Novavax. Novavax is new whereas we've given the mRNA vaccines to 170 million people in the U.S. alone. We may know more about the safety there than we do about Novavax." Wen said it's still important to emphasize the good safety record of the vaccines while still taking patient preference into account. "I have no concerns about the long-term effects of mRNA vaccines," Wen told MedPage Today. "That said, there are individuals who may have these concerns, and if another vaccine is what it takes to get them vaccinated, I think we should do everything we can to dispel misinformation while increasing options." The Real Key to HesitancyThe real way to get at vaccine hesitancy is for clinicians to understand the concerns that patients have and take them seriously, Wen said. "We need to speak to individuals and find out the reasons for their hesitancy, without judgment and with compassion," she said. "Yes, there are some people who are truly anti-science who are not going to be convinced to get the vaccine, but they are in the minority. There are many others who have questions and concerns that need to be answered." Schaffner added that primary care physicians, who often have existing close relationships with their patients, have a big role to play in addressing remaining hesitancy. "We have to respect why they feel that way and try to find out what is causing it," he said. "We never disrespect the person who is hesitant. We never dismiss them or belittle them. When they realize we will take their concerns seriously, they'll tell us what their issue is. Then we'll say, that's pretty common, I've heard that before, and their anxiety is eased." "The credibility of the doctor trying to provide the information goes up, and the patient is ready to hear you," Schaffner said. "You have to validate their concerns. If you dismiss or belittle them, you won't get anywhere." FULL STORY: www.medpagetoday.com/special-reports/exclusives/93166
|
|
|
Post by matte on Jun 20, 2021 1:21:19 GMT 10
Go get a tetanus or diphtheria booster, it helps: Tetanus, diphtheria boosters tied to less severe COVID-19By Nancy Lapid 15 JUNE 2021 REUTERS [...] Older individuals who have gotten a diphtheria or tetanus vaccine booster shot in the last 10 years may be at lower risk for severe COVID-19, a new study suggests. Using a large UK registry, researchers looked back at 10 years of immunization records from 103,409 participants with an average age of 71. They saw a trend toward a lower risk of a positive COVID-19 test in people who had gotten a tetanus or diphtheria booster shot during the study period, although the difference was small and might have been due to chance. There was, however, a statistically significant association between the booster shots and the odds of severe COVID-19. After accounting for age, sex, underlying respiratory diseases, and socioeconomic status, the odds of developing severe COVID-19 were 64% lower in people who had gotten a diphtheria booster and 50% lower in recipients of tetanus booster, according to a report posted on medRxiv on Saturday ahead of peer review. FULL STORY: www.reuters.com/business/healthcare-pharmaceuticals/delta-variant-doubles-risk-hospitalization-novavax-vaccine-highly-effective-2021-06-14/
|
|
|
Post by pim on Jun 20, 2021 12:55:24 GMT 10
Concerned about the latest AstraZeneca news? These 3 graphics help you make sense of the riskJune 18, 2021 theconversation.com/concerned-about-the-latest-astrazeneca-news-these-3-graphics-help-you-make-sense-of-the-risk-162175Yesterday’s announcement the AstraZeneca COVID vaccine would now only be recommended for the over 60s has highlighted the many ways we think about risk. The decision reflects a greater understanding of the real, but extremely low, risk of the clotting disorder called thrombosis with thrombocytopenia (TTS) for people aged 50-59, who are now recommended to have the Pfizer vaccine. But errors in the way we perceive these extremely small risks, called cognitive biases, reflect the fact that when our brains evolved we did not have to grapple with risks this small. So we struggle to make sense of them and perceive these events as being much more likely than they actually are. This can lead us to make decisions, such as not having a vaccine that could potentially save our life. And the misperception of the likelihood of TTS is one of the main reasons many are hesitant about receiving the AstraZeneca vaccine. So let’s start with what we know about the risk of dying from TTS associated with the AstraZeneca vaccine, expressed the traditional way, with words and numbers. Then we’ll present the same numbers graphically. What’s the risk of dying from TTS?Initially, we thought about 25% of people with TTS associated with the vaccine would die. But as we learnt more about how to recognise and treat these rare blood clots, the risk of dying from it has changed. In Australia, mortality is now down to around 4%. This is a low risk of dying from a syndrome with a small likelihood of occurring. So we can express TTS risk in another way. Two people in Australia have died from TTS after 3.8 million doses of the AstraZeneca vaccine delivered. This makes the likelihood of dying from this syndrome about 0.5 in a million, or if you prefer whole numbers, about 1 in 2 million. And now, with graphicsHere’s one way of representing 1 in 2 million visually. This figure shows just how small this risk is. Are you ready for some scrolling? As you can see, the risk of TTS is so small it is almost too small to communicate effectively in this format. Perhaps even more visually powerful is to compare the risk of dying from TTS to other risks we face in our lives, using a risk scale. This allows you to compare a range of risks and put them into perspective. As the risk of TTS is a one-off risk normally associated with the first dose of the AstraZeneca vaccine, one interesting comparison is with other one-off risks, such as adventure sports. AZ vaccination vs. adventure sportsRisk of dying from a TTS blood clot after a dose of AstraZeneca vaccine in Australia vs. one-off death risk from adventure sports. Mountain climbing - 14 per million Scuba diving - 10 per million Running with the bulls - 9 per million Skydiving - 8 per million Hang gliding - 8 per million Marathon running - 7 per million Rock climbing - 3 per million Bungee jumping - 2 per million AstraZeneca clotting - 0.5 per million As you can see, the risk of dying from TTS is far lower than many activities some of us get up to at the weekend. But not all of us spend our weekends scuba diving or rock climbing. So let’s look at the more common risks we take in our everyday lives but do not pay much attention to. This is not a perfect comparison, as the risks are averaged across the whole population, across the entire year. But it’s useful nevertheless. AZ vaccination vs. other activitiesRisk of dying from a TTS blood clot after a dose of AstraZeneca vaccine in Australia vs. annual risk of death from other activities. Car accident - 28 per million Homicide - 16 per million Drowning - 8 per million Pedestrian accident - 8 per million Lightning strike - 0.4 per million AstraZeneca clotting - 0.5 per million So the risk of dying from TTS after the first dose of the AstraZeneca vaccine is similar to the risk of being killed by lightning in a year in Australia. And this pales in comparison when compared to other risks, such as the risk of dying in a car accident. So what happens next?One of the challenges for public health has always been putting the risks and benefits of our health choices into perspective. This task is even harder when the risks involved are so small. Using visualisations like these is one way to effectively communicate just how small the risk of TTS is and also put this risk into perspective by comparing it to other risks we incur in our lives. When you fully appreciate how small the risk of TTS is, the decision to have the AstraZeneca vaccine to protect yourself and others becomes a much easier one to make.
|
|
|
Post by bender on Jun 20, 2021 15:46:46 GMT 10
That's weird that Hang Gliding and Sky Diving have the same risk of death. I always wondered why Hang Gliders didn't just wear a parachute in case things went bad, now I see that it doesn't really matter...…
|
|
|
Post by matte on Jun 20, 2021 15:52:53 GMT 10
I have put my name down for the vaccine, but due to my age I am not eligible so will have to wait to be contacted.
|
|
|
Post by Stellar on Jun 20, 2021 16:14:01 GMT 10
Go get a tetanus or diphtheria booster, it helps: Tetanus, diphtheria boosters tied to less severe COVID-19By Nancy Lapid 15 JUNE 2021 REUTERS [...] Older individuals who have gotten a diphtheria or tetanus vaccine booster shot in the last 10 years may be at lower risk for severe COVID-19, a new study suggests. Using a large UK registry, researchers looked back at 10 years of immunization records from 103,409 participants with an average age of 71. They saw a trend toward a lower risk of a positive COVID-19 test in people who had gotten a tetanus or diphtheria booster shot during the study period, although the difference was small and might have been due to chance. There was, however, a statistically significant association between the booster shots and the odds of severe COVID-19. After accounting for age, sex, underlying respiratory diseases, and socioeconomic status, the odds of developing severe COVID-19 were 64% lower in people who had gotten a diphtheria booster and 50% lower in recipients of tetanus booster, according to a report posted on medRxiv on Saturday ahead of peer review. FULL STORY: www.reuters.com/business/healthcare-pharmaceuticals/delta-variant-doubles-risk-hospitalization-novavax-vaccine-highly-effective-2021-06-14/Woo hoo! I got the triple whooping cough/diptheria/tetanus vaccine back in 2018 when there was a whooping cough epidemic on the Northern Beaches. There was a 500% increase of cases over here because of the selfish actions of stupid anti-vaxxer mothers who were putting other kids at risk. I had to get the booster so I could see my youngest grandson who was at that time too young to have the vaccine. So it's good to know it might help me in the unlikely - but still possible - event that I might get the virus whilst waiting for a more acceptable vaccine.
|
|
|
Post by matte on Jun 20, 2021 16:18:20 GMT 10
Same here, I have put my name down for the vaccine because I believe by the time I am accepted the Novavax vaccine will be available. I want to be at the front of the queue for Novavax. It is really the only acceptable vaccine. It is tried and proven technology.
|
|
|
Post by Gort on Jun 20, 2021 16:22:47 GMT 10
Yep, I would like to get Novavax.
|
|
|
Post by jody on Jun 20, 2021 18:54:33 GMT 10
I have no interest at all in getting this vaccine.
|
|
|
Post by matte on Jun 20, 2021 19:26:12 GMT 10
I have no interest at all in getting this vaccine. There is absolutely nothing wrong with not wanting to take the vaccine. The government needs to stop its threats against people opting against taking it.
|
|
|
Post by ponto on Jun 20, 2021 21:10:03 GMT 10
Free choice to vaccinate or not...it does seem the new Delta strain is breaking out, waiting may prove to be a bad choice.
|
|
|
Post by matte on Jun 20, 2021 22:05:15 GMT 10
Very irresponsible of Clive Palmer. However, we do live in a society where people can have their own view and can make it public. ‘Ludicrous’: Clive Palmer slammed for letters spreading COVID-19 misinformationBy Anthony Galloway June 20, 2021 SYDNEY MORNING HERALD Mining magnate Clive Palmer has been bombarding letterboxes urging people not to get a COVID-19 vaccine and citing discredited figures on the number of deaths caused by the jabs. Mr Palmer last week sent letters to households across the nation claiming the Therapeutic Goods Administration and the government are spreading “misleading information designed to create fear in the population”. “The Australian government’s Therapeutic Goods Administration report confirms 210 deaths and 24,000 adverse reactions after the COVID-19 vaccines. There are over 5000 deaths in the USA attributed to COVID vaccines including Pfizer,” Mr Palmer’s letter says. The TGA did say in May that there had been 210 deaths reported to have “occurred following immunisation”, but this did not mean they had been found to have been caused by COVID-19 vaccines. Chief Nursing and Midwifery Officer, Alison McMillan, on Sunday urged Australians to ignore Mr Palmer’s leaflets. FULL STORY: www.smh.com.au/politics/federal/ludicrous-clive-palmer-slammed-for-letters-spreading-covid-19-misinformation-20210620-p582ju.html
|
|
|
Post by matte on Jun 21, 2021 9:59:53 GMT 10
Who here thinks Clive Palmer's leaflets are the equivalent of yelling out bomb in an airport? I am in two minds about it. I fully believe in the ideal of freedom of speech, but I also dislike this false information. Perhaps if the government did a better job at communicating, these kinds of leaflets would be rejected by people and they wouldn't matter?
|
|
|
Post by ponto on Jun 21, 2021 12:02:52 GMT 10
Palmer is trying to attract punters who love Trump...and there is a % of people who would buy into Covid denial hoax thinking, just ask spin sprocket sporko who is off his cog on the issue.
|
|
|
Post by pim on Jun 21, 2021 13:03:22 GMT 10
I had my second AZ jab this morning.
|
|
|
Post by matte on Jun 21, 2021 13:18:44 GMT 10
I had my second AZ jab this morning. There is still a chance you could have a reaction causing the blood clotting syndrome. Slight, but could be fatal. You'll receive your vaccine passport on the Medicare app tomorrow then.
|
|
|
Post by pim on Jun 21, 2021 13:54:31 GMT 10
Gee Matt are you the portal through which all information passeth? Tell you what though stumblebum and you can have this one for free: I take my advice from qualified medical people. I don’t wait for the advice to pass through you. I go directly to the source. So when you presume to give gratuitous advice you’re out of line. Kapeesh? No I guess you don’t. So we’ll just have to go on taking the piss ...
|
|
|
Post by ponto on Jun 21, 2021 13:56:39 GMT 10
Son and law just had his 2nd jab of Pfizer, daughter felt unwell after her 2nd jab, but was right by the next day, while I have to wait until the end of July for 2nd jab of AZ, no ill effects from first AZ jab...none the less Pim and I are true patriot's for getting jabs.
|
|
|
Post by matte on Jun 21, 2021 14:26:19 GMT 10
Son and law just had his 2nd jab of Pfizer, daughter felt unwell after her 2nd jab, but was right by the next day, while I have to wait until the end of July for 2nd jab of AZ, no ill effects from first AZ jab...none the less Pim and I are true patriot's for getting jabs. How can you equate getting a vaccine to being patriotic? Is that how you feel when you get the flu jab? The truth is you have weighed up the risks and benefits for your own personal circumstances. Which is perfectly reasonable. But it isn't an act of patriotism.
|
|